⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001762683

Nanda Nisha

Reports to the SEC for 2 companies · STAMFORD, CT

Transactions

17

Companies

2

Filings

7

CIK

0001762683

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-04	Morphic Holding, Inc.Common StockA Award	Director	AAward	+23.2K sh	—	—	23,168
2023-06-01	Morphic Holding, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,535
2022-06-08	Morphic Holding, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,550
2021-08-19	Morphic Holding, Inc.Stock Option (right to buy Common Stock)A Award	Director	AAward	+24K sh	—	—	24,000
2021-08-19	Morphic Holding, Inc.Stock Option (right to buy Common Stock)A Award	Director	AAward	+18.2K sh	—	—	18,177
2019-02-15	Loxo Oncology, Inc.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−18.9K sh	$235.00	−$4.44M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−17K sh	$235.00	−$3.99M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−14.8K sh	$235.00	−$3.48M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−4,557 sh	$235.00	−$1.07M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−10.9K sh	$235.00	−$2.55M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−9,228 sh	$235.00	−$2.17M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−14.9K sh	$235.00	−$3.49M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−18.4K sh	$235.00	−$4.32M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−12K sh	$235.00	−$2.82M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−75K sh	$235.00	−$17.6M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−37K sh	$235.00	−$8.7M	0
2019-01-02	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+37K sh	—	—	37,000

Recent filings

7

Accepted (ET)
Jun 54
Nanda Nisha0001415889-24-015667
SEC(opens sec.gov)
Jun 24
Nanda Nisha0001209191-23-034040
SEC(opens sec.gov)
Jun 104
Nanda Nisha0001209191-22-036114
SEC(opens sec.gov)
Apr 294/A
Nanda Nisha0001209191-22-026238
SEC(opens sec.gov)
Aug 234
Nanda Nisha0001209191-21-053029
SEC(opens sec.gov)
Feb 154
Nanda Nisha0001567619-19-004575
SEC(opens sec.gov)
Jan 24
Nanda Nisha0001567619-19-000104
SEC(opens sec.gov)

Companies

2

Address

C/O LOXO ONCOLOGY, INC. 281 TRESSER BOULEVARD, 9TH FLOOR

STAMFORD, CT, 06901